Why the study?
What is the role, safety, and efficacy of pazopanib in the treatment of advanced soft tissue sarcoma?
What is the role, safety, and efficacy of pazopanib in the treatment of advanced soft tissue sarcoma?
Answers are grounded in this paper and cite their sources.
Pazopanib is a valid and cost-effective targeted therapy for advanced, pre-treated soft tissue sarcoma.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fotopoulos et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: